ANTI-C-MET-MEDICATION CONJUGATE

MA40725AUndetermined Publication Date: 2017-10-18SORRENTO THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40725
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-12-08
Filing Date: 2015-12-08
Publication Date: 2017-10-18

Application Information

Patent Timeline

08 Dec 2014

Priority

08 Dec 2015

Application

MA40725

18 Oct 2017

Publication

MA40725A

IPC: C07K16/28

CPC: C07K16/2863; A61K2039/505; A61K47/6809; A61K47/6817; A61K47/6871; A61K47/6849; A61P15/00; A61P35/00

Inventors: CHEN Gang; FU Yanwen

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

An antibody drug conjugate (ADC) is described, having an IgG antibody that binds to a c-met target conjugated to the two Cys sites in the hinge region of an IgG antibody. A method for treating breast cancer is further described, comprising the delivery of an effective amount of a c-met ADC.

Need to check novelty before this filing date? Find Prior Art